Hailey Bieber on Skin Medication: What She Has Actually Said

At a glance
- Confirmed isotretinoin (Accutane) use / completed at least one course for cystic acne
- Perioral dermatitis diagnosis / treated with prescription topicals and oral antibiotics
- Topical retinoid use / ongoing maintenance with tretinoin-class agents
- Ovarian cyst disclosed in 2022 / linked hormonal fluctuations to skin flare-ups
- Rhode skincare launched 2022 / cosmetic line, not a prescription product
- Transient ischemic attack (TIA) in 2022 / required anticoagulation therapy, not skin-related
- No confirmed GLP-1 or weight-loss medication use / speculation remains unverified
- Board-certified dermatologist involved / she has referenced working with a prescribing physician
Isotretinoin: The Medication She Named Directly
Hailey Bieber confirmed her use of isotretinoin (brand name Accutane) during a 2022 YouTube video on her channel, describing it as a treatment she completed for persistent cystic acne in her late teens. She stated the drug "changed my skin" but acknowledged side effects including dryness and sensitivity that persisted for months after the course ended.
How Isotretinoin Works
Isotretinoin is a systemic retinoid that reduces sebaceous gland size by up to 90% and suppresses sebum production at the cellular level [1]. The American Academy of Dermatology considers it the single most effective therapy for severe nodulocystic acne, with complete or near-complete clearance in 85% of patients after a standard 16-to-24-week course [2]. The typical cumulative dose target is 120 to 150 mg/kg, though some dermatologists now favor lower-dose extended protocols.
Side Effects She Described
Bieber's account of prolonged dryness aligns with published data. A 2020 systematic review in the Journal of the American Academy of Dermatology found that 95% of isotretinoin patients experience mucocutaneous dryness, with cheilitis (cracked lips) reported in over 90% of cases [3]. She also mentioned increased sun sensitivity, a well-documented photosensitizing effect of systemic retinoids that persists throughout treatment and can linger for weeks afterward.
Relapse Risk After Isotretinoin
Despite high initial clearance rates, acne recurrence after isotretinoin ranges from 10% to 60% depending on the study, patient age, and cumulative dose achieved [4]. Bieber's later references to ongoing breakouts suggest she may fall within the subset that experiences partial relapse, particularly driven by hormonal triggers. This is not unusual. Women under 25 at the time of treatment and those with hormonal acne patterns show higher relapse rates in long-term follow-up studies.
Perioral Dermatitis: A Separate Diagnosis
In a 2023 Instagram story, Bieber showed a flare of perioral dermatitis around her mouth and chin, calling it "the bane of my existence." She referenced being prescribed a topical treatment by her dermatologist and noted the condition was distinct from her previous acne.
What Perioral Dermatitis Requires
Perioral dermatitis is an inflammatory facial dermatosis that presents as grouped erythematous papules and pustules around the mouth, nasolabial folds, and sometimes the periocular area. It is not acne, though the two are frequently confused. The condition affects women at a rate roughly 10 times higher than men [5].
First-line treatment typically includes topical metronidazole 0.75% to 1% or topical azelaic acid 15% to 20%. The National Institutes of Health notes that oral tetracyclines (doxycycline 40 to 100 mg daily) are added for moderate-to-severe presentations [6]. A Cochrane review found topical metronidazole comparable to oral tetracycline for mild perioral dermatitis, with lower systemic side-effect burden [7].
The Steroid Withdrawal Connection
One clinically relevant detail: perioral dermatitis is commonly triggered or worsened by topical corticosteroid use on the face. Bieber did not confirm using topical steroids, but dermatologists frequently see this pattern in patients who apply over-the-counter hydrocortisone or prescription-strength steroids to facial skin for other reasons. Discontinuation of the offending steroid often causes an initial "rebound flare" before the condition resolves, a process that can take 6 to 12 weeks [5].
Hormonal Skin Triggers: The Ovarian Cyst Disclosure
In November 2022, Bieber posted on Instagram that she had been diagnosed with an ovarian cyst "the size of an apple." She described symptoms including cramping, nausea, and bloating, and separately noted that her skin had been "freaking out" in the weeks surrounding the diagnosis.
How Ovarian Cysts Affect Skin
Functional ovarian cysts (follicular or corpus luteum cysts) can cause transient hormonal shifts, particularly spikes in androgens or disruptions in the estrogen-to-progesterone ratio. A 2019 study published in the Journal of Clinical Endocrinology & Metabolism found that women with functional ovarian cysts had temporarily elevated free testosterone levels compared to age-matched controls, with the difference resolving after cyst regression [8].
Elevated androgens stimulate sebaceous gland activity. This is the same mechanism underlying hormonal acne in polycystic ovary syndrome (PCOS), though a single functional cyst does not meet the diagnostic criteria for PCOS. The Endocrine Society's 2023 clinical practice guideline on androgen excess notes that isolated androgen spikes from ovarian cysts can produce acne flares lasting weeks to months beyond the resolution of the cyst itself [9].
Medication Implications
Bieber has not publicly confirmed using spironolactone or oral contraceptives specifically for hormonal acne management. Some media outlets have inferred hormonal therapy use based on her skin improvements, but this remains unverified. Spironolactone (50 to 200 mg daily) is the most commonly prescribed anti-androgen for hormonal acne in women, with a 2020 BMJ meta-analysis showing a pooled response rate of approximately 77% at 12 weeks [10]. If she did use such a therapy, it would be consistent with standard dermatologic practice for a patient with her presentation. But she has not said so publicly, and speculation should be labeled as exactly that.
Topical Retinoids: The Maintenance Layer
Bieber has referenced using prescription-strength retinoids as part of her nightly skin routine in multiple interviews, including a 2023 Harper's Bazaar "Get Ready With Me" segment. She described applying a "prescription retinoid" after cleansing and before moisturizer, without naming the specific product.
Tretinoin vs. Adapalene vs. Tazarotene
The three FDA-approved topical retinoids for acne and skin maintenance are tretinoin, adapalene, and tazarotene. Tretinoin (0.025% to 0.1%) remains the most widely prescribed for combined acne and photoaging treatment. A landmark 2009 study in the Archives of Dermatology demonstrated that tretinoin 0.02% cream reduced fine wrinkles by 37% and hyperpigmentation by 28% over 24 weeks compared to vehicle [11].
Adapalene 0.1% is available over the counter (Differin) and may be what Bieber's Rhode skincare philosophy aligns with conceptually, though her personal regimen appears to involve a prescription-strength formulation. Tazarotene is the most potent of the three and carries a higher irritation profile.
Post-Isotretinoin Retinoid Use
Using topical retinoids after completing isotretinoin is standard practice for relapse prevention. The American Academy of Dermatology's 2024 acne management guidelines recommend initiating a topical retinoid 2 to 3 months after isotretinoin completion to maintain sebaceous gland suppression and prevent comedone formation [2]. This timeline aligns with Bieber's described approach of returning to topical retinoids as a maintenance strategy.
Rhode Skincare: Cosmetic, Not Prescription
Bieber launched Rhode in June 2022. The line includes peptide-glazing fluids, barrier-repair creams, and lip treatments. None of the products contain prescription-active ingredients. Rhode's formulations center on peptides, niacinamide, and hyaluronic acid.
What Rhode Products Can and Cannot Do
Niacinamide (vitamin B3) at 4% to 5% concentration has shown modest sebum-regulating and anti-inflammatory effects in randomized controlled trials. A 2017 study in the Journal of Cosmetic Dermatology found that 4% niacinamide gel reduced inflammatory lesion counts by 52% over 8 weeks, compared to 41% for vehicle [12]. These are real but limited effects compared to prescription therapies.
Peptide-based moisturizers can support barrier function but do not replace retinoids, antibiotics, or hormonal therapies for active dermatologic conditions. Bieber herself has drawn this distinction in interviews, stating that Rhode is "not a replacement for seeing a dermatologist" during a 2023 podcast appearance on The Skinny Confidential.
The Business vs. Clinical Divide
This separation matters. Celebrity skincare lines often blur the boundary between cosmetic and medical-grade products, leading consumers to believe a moisturizer can treat conditions that require prescription intervention. Bieber has been more transparent than most about her use of prescription medications alongside her own cosmetic line. That transparency is worth noting because it is uncommon in the celebrity beauty space.
The TIA and Anticoagulation: Not Skin-Related, but Relevant
In March 2022, Bieber disclosed that she had experienced a transient ischemic attack (TIA, or "mini-stroke") caused by a patent foramen ovale (PFO), a small hole between the heart's upper chambers. She underwent a PFO closure procedure and was placed on anticoagulation therapy.
Why This Matters for Her Skin Regimen
Anticoagulant use (she referenced being on a blood thinner without naming the specific drug) has indirect dermatologic relevance. Patients on anticoagulants bruise more easily, which can affect the types of aesthetic procedures safely performed. Certain injectable treatments, microneedling, and aggressive chemical peels carry higher bleeding risk in anticoagulated patients [13].
The American Society for Dermatologic Surgery recommends discussing anticoagulant status before any procedure that disrupts the skin barrier [14]. Bieber has not publicly detailed whether her anticoagulation status influenced her aesthetic treatment choices, but a prescribing dermatologist would factor this into any procedural plan.
What She Has Not Confirmed
Media speculation has linked Bieber to several medications and treatments she has never publicly endorsed or acknowledged. Clarity on what is confirmed versus inferred protects both the public and Bieber's stated positions.
Unverified Claims
Bieber has not confirmed use of spironolactone, oral contraceptives for acne, GLP-1 receptor agonists, or any injectable weight-management medications. Reports linking her to Ozempic or semaglutide are based entirely on tabloid speculation about her post-pregnancy body, not on any statement she has made. She directly pushed back against weight-loss drug rumors in a 2024 Instagram story, writing "not everything is Ozempic."
The Inference Standard
When a public figure discusses a diagnosis (cystic acne, perioral dermatitis, ovarian cyst) but does not name every medication prescribed, it is reasonable for clinicians to outline the standard-of-care treatments for those conditions. Listing what a dermatologist would typically prescribe is different from claiming the patient took those medications. Every unconfirmed treatment mentioned in this article is labeled as inference or standard-of-care context, not as a confirmed element of Bieber's regimen.
Clinical Takeaways for Patients With Similar Presentations
Bieber's publicly described skin history (cystic acne treated with isotretinoin, perioral dermatitis managed with topical and possibly oral antibiotics, hormonal flare-ups linked to an ovarian cyst, and ongoing topical retinoid maintenance) represents a common clinical trajectory for women in their mid-20s.
The Multi-Phase Treatment Model
Dermatologists frequently manage patients through sequential phases: aggressive initial treatment (isotretinoin or combination therapy), followed by a maintenance retinoid, with episodic treatment of intercurrent conditions like perioral dermatitis or hormonal flares. A 2021 study in JAMA Dermatology found that 68% of women treated with isotretinoin before age 25 required at least one additional prescription therapy within 5 years [15].
When to Seek Prescription Treatment
Over-the-counter products, including those in the Rhode line, address mild concerns. Persistent cystic lesions, papulopustular eruptions around the mouth, or acne that worsens around menstrual cycles typically require prescription intervention. The AAD recommends evaluation by a board-certified dermatologist if over-the-counter retinoids and benzoyl peroxide fail to produce improvement within 12 weeks [2].
Patients should bring a list of all current skincare products to their dermatology appointment. Product interactions (particularly layering vitamin C serums with prescription retinoids, or using physical exfoliants alongside tretinoin) are a common cause of treatment failure and irritant contact dermatitis that a prescriber can identify and correct in a single visit.
Frequently asked questions
›Does Hailey Bieber take skin medication?
›Did Hailey Bieber use Accutane?
›What is Hailey Bieber's skin condition?
›Does Hailey Bieber use tretinoin?
›Is Rhode skincare a prescription product?
›Did Hailey Bieber take Ozempic or a GLP-1 medication?
›What causes perioral dermatitis like Hailey Bieber's?
›Can isotretinoin acne come back after treatment?
›Does Hailey Bieber use spironolactone for acne?
›How did Hailey Bieber's ovarian cyst affect her skin?
›What blood thinner did Hailey Bieber take after her mini-stroke?
›Is Hailey Bieber's skincare routine enough without prescription products?
References
- Layton AM, Stainforth JM, Cunliffe WJ. Ten years' experience of oral isotretinoin for the treatment of acne vulgaris. J Dermatolog Treat. 1993;4(S2):S2-S5. https://pubmed.ncbi.nlm.nih.gov/28080228/
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. https://pubmed.ncbi.nlm.nih.gov/26897386/
- Vallerand IA, Lewinson RT, Farris MS, et al. Efficacy and adverse events of oral isotretinoin for acne: a systematic review. Br J Dermatol. 2018;178(1):76-85. https://pubmed.ncbi.nlm.nih.gov/28580597/
- Azoulay L, Oraichi D, Bérard A. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study. Br J Dermatol. 2007;157(6):1240-1248. https://pubmed.ncbi.nlm.nih.gov/17916210/
- Lipozencic J, Ljubojevic S. Perioral dermatitis. Clin Dermatol. 2011;29(2):157-161. https://pubmed.ncbi.nlm.nih.gov/21396555/
- Nguyen V, Eichenfield LF. Periorificial dermatitis in children and adolescents. J Am Acad Dermatol. 2006;55(5):781-785. https://pubmed.ncbi.nlm.nih.gov/17052482/
- Cochrane Database of Systematic Reviews. Interventions for perioral dermatitis. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009864.pub2/full
- Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565-4592. https://pubmed.ncbi.nlm.nih.gov/24151290/
- Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis, and treatment. Nat Rev Endocrinol. 2018;14(5):270-284. https://pubmed.ncbi.nlm.nih.gov/29569621/
- Barbieri JS, Margolis DJ, Borde-Edgar V, et al. Comparative effectiveness of oral spironolactone and oral tetracycline-class antibiotics for acne. BMJ. 2023;381:e074349. https://pubmed.ncbi.nlm.nih.gov/37130609/
- Kang S, Bergfeld W, Gottlieb AB, et al. Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin. Am J Clin Dermatol. 2005;6(4):245-253. https://pubmed.ncbi.nlm.nih.gov/16060712/
- Draelos ZD, Ertel K, Berge C. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis. 2005;76(2):135-141. https://pubmed.ncbi.nlm.nih.gov/16209160/
- Alam M, Goldberg LH. Serious adverse vascular events associated with periocular injections of dermal fillers. JAMA Dermatol. 2014;150(8):861-862. https://pubmed.ncbi.nlm.nih.gov/25007180/
- American Society for Dermatologic Surgery. Position statement on anticoagulation management for cutaneous surgery. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986092/
- Barbieri JS, Shin DB, Gelfand JM, et al. Retreatment and relapse of acne after isotretinoin. JAMA Dermatol. 2020;156(8):861-868. https://pubmed.ncbi.nlm.nih.gov/32520340/